Actionable news
All posts from Actionable news
Actionable news in PFE: PFIZER Inc,

Servier and Pfizer get rights to Cellectis cancer cell therapy

U.S. drugmaker Pfizer and France's Servier have snapped up rights to a promising cell therapy developed by French biotech firm Cellectis to fight blood cancers.

The so-called CAR T cell technology used by Cellectis involves reprogramming immune system cells to hunt out cancer. The "off-the-shelf" approach recently proved very successful in the case of a baby whom doctors thought almost certain to die.

Cellectis said on Thursday that Servier had exercised an option to acquire the exclusive worldwide...